IMD-6-0296 © 2007
Billington; Corey; Jäger; François
InnoCentive spun off Eli Lilly the Pharmaceutical Giant in the year 2000. The objective of the firm was to associate businesses with R&D difficulties to a were able to solve one of the issues posted on the InnoCentive site. Worldwide community of prospective solvers who would be rewarded if they
Learning objectives: Supervisors usually have a conventional view of what R&D should look like. Mindsets that are traditional open to new opportunities in R&D with the discovery of new processes in the open innovation area and additionally the use of seeker-solver networks.
Subjects: Innovation; Open-innovation; R&D; procurement; sourcing; process; pharmaceutical; chemistry
Settings: Global; R&D; Research & development; Dot com; 20-25 employees; 2000-2007
Related Case Solutions & Analyses:
What Can a Mosquito Do to an Elephant (C)
Strategic Activism: The Rainforest Action Network
CSFBs China Unicom Incident
Atlanta Park Medical Center vs. Hamlin Asset Management
The Melbourne City Link
Megalith Inc. — Hay Associates (A)
Gabriel Resources: Foreign Direct Investment in Romania
Norfolk Southern Corporation—Century Bonds
How to Win Investors Over
Communications Satellite Corp., Spanish Version
